[Download]

FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat most cancers, Alzheimer’s illness, opioid withdrawal, pain and pet anxiety

FDA has issued a warning letter to Curaleaf Inc. for illegally selling unapproved cannabidiol products online with unsubstantiated claims.
FDA has issued a warning letter to Curaleaf Inc. for illegally selling unapproved cannabidiol products online with unsubstantiated claims.

Original articleOriginal article
Author: US FDA

The latest Tweets from U.S. FDA (@US_FDA). Here you'll find the latest US Food and Drug Administration news and information. Privacy Policy - http://t.co/4HK1KrSwBs

US FDA has recently written 2 articles on similar topics including :
  1. "FDA is proposing new health warnings on cigarette packages and in ads to promote greater public understanding of the negative health consequences of smoking". (August 15, 2019)
  2. "FDA has notified four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authorization". (August 8, 2019)
Posted on  , , ,